glp 1 receptor agonists in idiopathic intracranial hypertension Recurrent Hypertension–Related Papilledema After Abrupt Discontinuation of Semaglutide: JNO Article: https://bit.ly/JNO_recurr_IIH_GLP1RA #brain #eye #vision #research #Neurology #NeuroOphth #Ophthalmology #Medicine #Papilledema Novel use of GLP-1 receptor
Description
Using Savings Programs and Shopping Smart Manufacturer savings cards and pharmacy discount programs can substantially lower out-of-pocket costs
But the real-world concerns I hear every day are not hard to predict: How long do I have to stay on this? What happens if I stop? Will insurance keep paying? Can I afford this for years? Is there a better long-term alternative? Those are smart questions
Retatrutide May Be Studied for Other Health Conditions Retatrutide is mainly known for weight-loss research, but scientists are also studying it for other health problems
Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis
In the first few weeks on the drug, you may experience mild side effects as your body starts to adjust to the medication
GLP-1R agonists modulate enteric immune responses through the intestinal intraepithelial lymphocyte GLP-1R
